Your browser doesn't support javascript.
loading
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.
Hagström, Anna; Kal Omar, Ruba; Williams, Pete A; Stålhammar, Gustav.
Affiliation
  • Hagström A; Department of Medicine, Karolinska Institutet, D1:04, 171 76, Stockholm, Sweden. anna.hagstrom@stud.ki.se.
  • Kal Omar R; Department of Medicine, Karolinska Institutet, D1:04, 171 76, Stockholm, Sweden. ruba.kal.omar@stud.ki.se.
  • Williams PA; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 171 64, Stockholm, Sweden.
  • Stålhammar G; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 171 64, Stockholm, Sweden.
BMC Cancer ; 22(1): 398, 2022 Apr 13.
Article in En | MEDLINE | ID: mdl-35413810
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Melanoma / Melatonin Type of study: Systematic_reviews Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uveal Neoplasms / Melanoma / Melatonin Type of study: Systematic_reviews Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: